Clinical depression follow-up

Revision as of 16:09, 9 October 2014 by Rstiles (talk | contribs) (Created page with "__NOTOC__ {{Clinical depression}} {{CMG}} ==Follow-up== According to VA/DoD Clinical Practice Guidelines for Management of Major Depressive Disorder, recommended follow-up p...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Clinical Depression Microchapters

Home

Patient Information

Major Depressive Disorder (Patient Information)

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Clinical Depression from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Substance/Medication-induced Depressive Disorder

Depressive Disorder due to a Medical Condition

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Psychotherapy

ECT

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Follow-up

Follow-Up

Case Studies

Case #1

Clinical depression follow-up On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Clinical depression follow-up

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Clinical depression follow-up

CDC on Clinical depression follow-up

Clinical depression follow-up in the news

Blogs on Clinical depression follow-up

Directions to Hospitals Treating Clinical depression

Risk calculators and risk factors for Clinical depression follow-up

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Follow-up

According to VA/DoD Clinical Practice Guidelines for Management of Major Depressive Disorder, recommended follow-up period from time of initial diagnosis is four to six weeks. At time of follow-up, a repeat PHQ-9 and risk for suicide should be completed in order to assess treatment response. How well treatment was tolerated, adherence to treatment, other influential medical problems and psychosocial barriers to therapy should also be addressed at time of follow-up.

References